LigandLGND
NASDAQPharmaceuticals
No cached AI snapshot yet for LGND.
Be the first to run a multi-agent analysis on this ticker.
Key Stats
47 employees19.94M shares outstandinglisted 1994-11-25
Next earnings ~May 5, 2026 · Ex-dividend Jul 2, 2010 · Dividend $0.08 irregular
About Ligand
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
Latest News
Showing market-wide stock news
Gold Price Forecast: XAU/USD consolidates below $4,350 ahead of Fed decision
Bond market woes likely a factor for Fed, but intervention seen as unlikely
German Stocks Gain Ground On Oil Decline, Fed Looms
Warsh’s words may matter more than the anticipated Fed rate hike
Federal Reserve interest rate hikes usually pound stocks, but then something surprising happens
FOMC preview: Rate hike priced in as markets await policy guidance
Related Stocksin Pharmaceuticals
Ready to see the live AI view on LGND?
Launch a real-time multi-agent room — Claude, GPT, Gemini, DeepSeek, Grok, and Qwen analyzing LGND side-by-side with live signals.